ResMed Inc (RME.HA)
Hanover - Hanover Delayed Price. Currency in EUR
Add to watchlist
As of 08:01AM CEST. Market open.
| Previous Close | 176.55 |
| Open | 172.30 |
| Bid | 173.45 x N/A |
| Ask | 176.95 x N/A |
| Day's Range | 172.30 - 172.30 |
| 52 Week Range | 127.55 - 202.30 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ZacksQIAGEN (QGEN) Backs New AAP Guidelines Supporting QFT-Plus Test
QIAGEN (QGEN) supports the new TB screening guidelines from AAP, recommending IGRA tests like QFT-Plus to screen at-risk children of all ages.
ZacksTop Research Reports for NVIDIA, Amazon.com & UnitedHealth
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Amazon.com, Inc. (AMZN) and UnitedHealth Group Incorporated (UNH).
Barrons.comResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn’t Be.
Shares of ResMed, a maker of CPAP and other sleep-apnea airway machines, have dropped because of weight-loss developments. It’s an overreaction.
© 2024 Yahoo. All rights reserved.